Author: admin

In April, a patient who was identified during the data collection process with advanced cirrhosis had extreme difficulty initiating and continuing his hepatitis C treatment facility, which was JNIMS in Imphal. Action Taken: In April, after speaking and meeting with the patient’s treatment center, he was transferred to a health facility at Thoubal district where he […]

During April to June survey period, the interviewer team met a number of people who inject drugs who had already completed their treatment for hepatitis C, but had not undergone virus testing to confirm sustained virologic response (SVR). Action Taken: In between the April to June, 6 people who inject drugs use were successfully referred for […]

In June 2023, while conducting a CLM interview, an interviewer met a teenager who had been abandoned by her father after she was born, and was being raised by her mother. Both mother and daughter had been self-reliant, but her mother became unemployed and unable to support their needs. She sought financial assistance from the […]

In July 2023, interviewers met a woman living with HIV who was on 2nd-line antiretroviral therapy, but was having to use the pediatric formulation of lopinavir/ritonavir due to stock-outs of the adult formulation. This required her to take multiple pills and she became uncertain over the reliability of the medicines. Action Taken: After a phone conversation […]

In March 2023, CLM team members met a woman living with HIV in a sero-discordant relationship. After living together for about 4 years, her husband started abusing her mentally and physically due to her HIV positive status. She was disowned by her husband and forced out of her home, but was not granted a legal […]

On 29 May 2023, Peduli Hati, the Director General of Pharmaceutical and Medical Devices, and representatives of the Communication and Public Service Bureau and the Indonesian CDC discussed procurement of additional hepatitis C medicines and rapid molecular testing machines using the national Global Fund budget. Action taken: By July 2023, there was an agreement to procure […]

After a protest rally on 29 May 2023 on the need to create access to hepatitis C treatment, the government procured daclatasvir through an emergency purchase mechanism the next day on 30 May 2023. Action taken: On 31 May 2023 the Hepatitis Working Team, Peduli Hati and the Provincial Health Office conducted a coordination meeting […]